Metabolites as novel biomarkers for childhood obesity‐related traits in Mexican–American children

Although newer approaches have identified several metabolites associated with obesity, there is paucity of such information in paediatric populations, especially among Mexican–Americans (MAs) who are at high risk of obesity. Therefore, we performed a global serum metabolite screening in MA children to identify biomarkers of childhood obesity.

[1]  L. Barkai,et al.  Cardiometabolic risk factors and insulin resistance in obese children and adolescents: relation to puberty , 2015, Pediatric obesity.

[2]  A. Jurko,et al.  Epicardial adipose tissue and cardiometabolic risk factors in overweight and obese children and adolescents , 2014, Pediatric obesity.

[3]  L. Almasy,et al.  Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study , 2013, Human Genetics.

[4]  M. Kleber,et al.  Childhood Obesity Is Associated with Changes in the Serum Metabolite Profile , 2012, Obesity Facts.

[5]  Brian K. Lee,et al.  Joint Effects of Obesity and Vitamin D Insufficiency on Insulin Resistance and Type 2 Diabetes , 2012, Diabetes Care.

[6]  P. Iozzo,et al.  The interaction of blood flow, insulin, and bradykinin in regulating glucose uptake in lower-body adipose tissue in lean and obese subjects. , 2012, The Journal of clinical endocrinology and metabolism.

[7]  K. Flegal,et al.  Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. , 2012, JAMA.

[8]  M. Mestek,et al.  Influence of Abdominal Obesity on Vascular Endothelial Function in Overweight/Obese Adult Men , 2011, Obesity.

[9]  Peter Kovacs,et al.  Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. , 2011, Journal of proteome research.

[10]  A. Marian,et al.  Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy , 2011, European journal of clinical investigation.

[11]  M. DeBoer.  Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention , 2011, Expert review of endocrinology & metabolism.

[12]  Z. Peng,et al.  Protective effect of HDL on endothelial NO production: the role of DDAH/ADMA pathway , 2011, Molecular and Cellular Biochemistry.

[13]  J. Weng,et al.  Targeting metabolic syndrome: Candidate natural agents , 2010, Journal of diabetes.

[14]  J. H. Lee,et al.  Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). , 2010, Journal of proteome research.

[15]  N. Brown,et al.  Endogenous Nitric Oxide Contributes to Bradykinin-Stimulated Glucose Uptake but Attenuates Vascular Tissue-Type Plasminogen Activator Release , 2010, Journal of Pharmacology and Experimental Therapeutics.

[16]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[17]  G. Berglund,et al.  Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men. , 2009, Atherosclerosis.

[18]  Martin Kussmann,et al.  OMICS-driven biomarker discovery in nutrition and health. , 2006, Journal of biotechnology.

[19]  Alessandro Antonelli,et al.  3,5‐Diiodo‐L‐thyronine powerfully reduces adiposity in rats by increasing the burning of fats , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Katherine M Flegal,et al.  Prevalence and trends in overweight among US children and adolescents, 1999-2000. , 2002, JAMA.

[21]  G. Colditz,et al.  The disease burden associated with overweight and obesity. , 1999, JAMA.

[22]  S. Wolfrum,et al.  Pharmacology and cardiovascular implications of the kinin-kallikrein system. , 1999, Japanese journal of pharmacology.

[23]  M. Shichiri,et al.  Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts. , 1998, European journal of endocrinology.

[24]  A. Schmaier,et al.  Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. , 1997, Blood.

[25]  G. Dimitriadis,et al.  The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats , 1997, European journal of clinical investigation.

[26]  S. Weinstein,et al.  Thyroid Hormone Increases Basal and Insulin-Stimulated Glucose Transport in Skeletal Muscle: The Role of GLUT4 Glucose Transporter Expression , 1994, Diabetes.

[27]  S. Weinstein,et al.  Thyroid hormone increases muscle/fat glucose transporter gene expression in rat skeletal muscle. , 1991, Endocrinology.

[28]  이은직.  The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes. , 2012 .

[29]  J. Oppenheimer,et al.  Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis in the rat. , 1991, The Journal of clinical investigation.

[30]  D. Proud,et al.  Kinin formation: mechanisms and role in inflammatory disorders. , 1988, Annual review of immunology.